CMBA
GSK icon

C.M. Bidwell & Associates’s GSK GSK Stock Holding History

C.M. Bidwell & Associates’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,331
Closed -$72K – 501
2022
Q2 		$72K Sell
1,331
-4
-0.3% -$221 0.06% 254
2022
Q1 		$73K Hold
1,335
– – 0.05% 266
2021
Q4 		$74K Buy
+1,335
New +$69.4K 0.05% 264

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

C.M. Bidwell & Associates's GSK Position: Q3 2022 in Review

C.M. Bidwell & Associates sold out of GSK (GSK) in Q3 2022, closing a stake of 1,331 shares — an estimated $72K sold.

C.M. Bidwell & Associates first reported a position in GSK in Q4 2021 and held it in 3 quarters. The position peaked at $74K in Q4 2021. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • C.M. Bidwell & Associates reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 1,331 GSK shares in Q3 2022, an estimated $72K.
  • C.M. Bidwell & Associates first reported a position in GSK in Q4 2021 and held it in 3 quarters.
  • C.M. Bidwell & Associates's GSK position peaked at $74K in Q4 2021.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on C.M. Bidwell & Associates's 13F filing for Q3 2022, filed 14 Nov 2022.